Literature DB >> 32085445

Arginine Catabolic Mobile Element in Evolution and Pathogenicity of the Community-Associated Methicillin-Resistant Staphylococcus aureus Strain USA300.

Kaiyu Wu1, John Conly1,2,3,4,5, Jo-Ann McClure5, Habib A Kurwa3, Kunyan Zhang1,2,3,4,5.   

Abstract

USA300 is a predominant community-associated methicillin-resistant Staphylococcus aureus strain which carries an arginine catabolic mobile element (ACME). ACME contains potential virulence factors including an arginine deiminase (arc) pathway and an oligopeptide permease (opp-3) system, which are proposed to play a role in bacterial virulence and transmission. However, the role of ACME in evolution and pathogenicity of USA300 remains to be elucidated. ACME and arcA deletion mutants were created by allelic replacement from a USA300 clinical isolate. By comparing wild type and isogenic ACME deletion USA300 strains, ACME was shown not to contribute to bacterial survival on plastic surfaces, and mouse skin surfaces. ACME did not contribute to bacterial virulence in cell invasion and cytotoxicity assays, invertebrate killing assays and a mouse skin infection model. Wild-type ACME negative USA300 clinical isolates showed similar associations with invasive anatomic sites as ACME positive isolates. Our experiments also demonstrated that ACME can spontaneously excise from the bacterial chromosome to generate an ACME deletion strain at a low frequency. Our results do not support that the ACME element alone is a significant factor in the transmission and virulence of USA300 strain, and ACME may have been coincidently incorporated into the genome of USA300.

Entities:  

Keywords:  ACME; CA-MRSA; Staphylococcus aureus; USA300; epidemiology; evolution; pathogenicity

Year:  2020        PMID: 32085445     DOI: 10.3390/microorganisms8020275

Source DB:  PubMed          Journal:  Microorganisms        ISSN: 2076-2607


  1 in total

1.  Biology and Pathogenesis of Staphylococcus Infection.

Authors:  Valentina Virginia Ebani
Journal:  Microorganisms       Date:  2020-03-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.